IL149211A0 - Improved mutation analysis of the nf1 gene - Google Patents

Improved mutation analysis of the nf1 gene

Info

Publication number
IL149211A0
IL149211A0 IL14921100A IL14921100A IL149211A0 IL 149211 A0 IL149211 A0 IL 149211A0 IL 14921100 A IL14921100 A IL 14921100A IL 14921100 A IL14921100 A IL 14921100A IL 149211 A0 IL149211 A0 IL 149211A0
Authority
IL
Israel
Prior art keywords
gene
mutation analysis
improved mutation
improved
analysis
Prior art date
Application number
IL14921100A
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Publication of IL149211A0 publication Critical patent/IL149211A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14921100A 1999-10-18 2000-10-18 Improved mutation analysis of the nf1 gene IL149211A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP99870216 1999-10-18
EP00870122 2000-06-05
US21192900P 2000-06-16 2000-06-16
PCT/EP2000/010255 WO2001029251A2 (en) 1999-10-18 2000-10-18 Improved mutation analysis of the nf1 gene

Publications (1)

Publication Number Publication Date
IL149211A0 true IL149211A0 (en) 2002-11-10

Family

ID=26074255

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14921100A IL149211A0 (en) 1999-10-18 2000-10-18 Improved mutation analysis of the nf1 gene

Country Status (6)

Country Link
US (1) US20030134272A1 (en)
EP (1) EP1255858A2 (en)
JP (1) JP2003529335A (en)
AU (1) AU1140101A (en)
IL (1) IL149211A0 (en)
WO (1) WO2001029251A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070148636A1 (en) * 2005-12-23 2007-06-28 Song Min-Sun Method, compositions and kits for preparation of nucleic acids
CA2820315A1 (en) * 2009-12-09 2011-06-16 Ezygene Pty Ltd Hyperprimers
CN103045605B (en) * 2012-12-26 2015-01-07 首都医科大学宣武医院 I-type neurofibroma NF1 gene mutation nucleotide sequence related to cerebrovascular stenosis and application thereof
CA2903805A1 (en) 2013-03-14 2014-10-02 Mylan Inc. Glatiramer acetate response biomarker mrna potency assay
CA2928084A1 (en) 2013-10-24 2015-04-30 Mylan Inc. Human t cell line assay for evaluating the immunologic identity of glatiramer acetate preparations
EP3218393A1 (en) * 2014-11-12 2017-09-20 Recombinetics, Inc. Heterozygous modifications of tumor suppressor genes and swine model of neurofibromatosis type 1
CN106755399B (en) * 2016-12-21 2019-11-15 杭州艾诺医学检验所有限公司 A kind of I type neurofibromatosis pathogenic mutation gene and the Etiologic reagent based on this mutated gene
KR101925974B1 (en) * 2017-04-05 2018-12-06 울산대학교 산학협력단 Composition for diagnosis of neurofibromatosis comprising long PCR primer set based on genomic DNA
CN109988824A (en) * 2019-04-30 2019-07-09 明码（上海）生物科技有限公司 A kind of primer and method, kit detecting the gene mutation of NF1 gene extron
CN110184275B (en) * 2019-06-19 2021-06-04 中国人民解放军陆军军医大学第一附属医院 NF1 new mutation pathogenic gene, application and kit
US20210040472A1 (en) 2019-08-09 2021-02-11 Nutcracker Therapeutics, Inc. Methods and apparatuses for manufacturing for removing material from a therapeutic composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605799A (en) * 1990-07-12 1997-02-25 University Of Utah Research Foundation Somatic mutations in neurofibromatosis type 1 gene in human tumors

Also Published As

Publication number Publication date
WO2001029251A8 (en) 2003-02-06
US20030134272A1 (en) 2003-07-17
WO2001029251A3 (en) 2002-08-01
AU1140101A (en) 2001-04-30
JP2003529335A (en) 2003-10-07
EP1255858A2 (en) 2002-11-13
WO2001029251A2 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
PL343599A1 (en) Genes controlling diseases
EP1077996A4 (en) HUMAN EDG3sb GENE
IL149211A0 (en) Improved mutation analysis of the nf1 gene
HUP0104046A3 (en) Adenovirus-mediated gene therapy
HK1031983A1 (en) Gene mutant animals
AU6387000A (en) Serial analysis of genetic alterations
AU3178200A (en) Genetic analysis
HUP0105208A3 (en) Gene therapy-1
GB9817704D0 (en) Gene switch
IL146332A0 (en) PrP-LIKE GENE
EP1174499A4 (en) Novel amidase gene
EP1241256A4 (en) Novel gene and use thereof
GB9924981D0 (en) Gene therapy
EP1215284A4 (en) Tsg-like gene
GB9900009D0 (en) Gene therapy
AU4577099A (en) Human fast-1 gene
GB0406539D0 (en) Gene therapy
GB9924604D0 (en) Genetic switch
AU3444300A (en) Genetic analysis
EP1182256A4 (en) Pollinosis-associated gene 513
GB9810997D0 (en) Genes & enzymes
GB9906833D0 (en) Genetic analysis
GB9616646D0 (en) Insect gene mutation
AU2001263307A8 (en) Haplotypes of the ccr3 gene
GB9819721D0 (en) Novel gene